|
Volumn 21, Issue 9, 2006, Pages 2352-2353
|
Progression of renal disease - Can we forget about inhibition of the renin-angiotensin system? Authors' reply
|
Author keywords
ACE inhibitors; Angiotensin receptor antagonists; Antihypertensive drugs; Clinical trials; End stage renal disease
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
CREATININE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
PLACEBO;
ALBUMINURIA;
BLOOD PRESSURE REGULATION;
CARDIOVASCULAR DISEASE;
CHRONIC KIDNEY DISEASE;
CLINICAL TRIAL;
CREATININE BLOOD LEVEL;
DISEASE COURSE;
EDITORIAL;
FOLLOW UP;
HIGH RISK PATIENT;
HUMAN;
INCIDENCE;
KIDNEY FAILURE;
MEDICAL DECISION MAKING;
META ANALYSIS;
PRIORITY JOURNAL;
RANDOMIZATION;
RENAL PROTECTION;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
SYSTEMATIC REVIEW;
|
EID: 33750443932
PISSN: 09310509
EISSN: 14602385
Source Type: Journal
DOI: 10.1093/ndt/gfl316 Document Type: Editorial |
Times cited : (1)
|
References (7)
|